Tower Research Capital (TRC)’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19
| Closed | -$195 | – | 6433 |
|
|
2023
Q2 | $195 | Sell |
19
-85
| -82% | -$872 | ﹤0.01% | 5723 |
|
|
2023
Q1 | $1K | Buy |
+104
| New | +$1K | ﹤0.01% | 5711 |
|
|
2022
Q1 | – | Sell |
-883
| Closed | -$9K | – | 6856 |
|
|
2021
Q4 | $9K | Sell |
883
-202
| -19% | -$2.06K | ﹤0.01% | 4750 |
|
|
2021
Q3 | $11K | Buy |
+1,085
| New | +$11K | ﹤0.01% | 4278 |
|